These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 14525943)
1. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. Hwang YC; Bakr S; Ellery CA; Oates PJ; Ramasamy R FASEB J; 2003 Dec; 17(15):2331-3. PubMed ID: 14525943 [TBL] [Abstract][Full Text] [Related]
2. Central role for aldose reductase pathway in myocardial ischemic injury. Hwang YC; Kaneko M; Bakr S; Liao H; Lu Y; Lewis ER; Yan S; Ii S; Itakura M; Rui L; Skopicki H; Homma S; Schmidt AM; Oates PJ; Szabolcs M; Ramasamy R FASEB J; 2004 Aug; 18(11):1192-9. PubMed ID: 15284219 [TBL] [Abstract][Full Text] [Related]
3. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury. Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188 [TBL] [Abstract][Full Text] [Related]
4. Aldose reductase activation is a key component of myocardial response to ischemia. Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943 [TBL] [Abstract][Full Text] [Related]
5. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts. Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645 [TBL] [Abstract][Full Text] [Related]
6. Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts. Li Q; Hwang YC; Ananthakrishnan R; Oates PJ; Guberski D; Ramasamy R Cardiovasc Diabetol; 2008 Oct; 7():33. PubMed ID: 18957123 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Ramasamy R; Oates PJ; Schaefer S Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707 [TBL] [Abstract][Full Text] [Related]
9. Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury. Cheung AK; Lo AC; So KF; Chung SS; Chung SK Exp Eye Res; 2007 Nov; 85(5):608-16. PubMed ID: 17727843 [TBL] [Abstract][Full Text] [Related]
10. Sorbitol dehydrogenase inhibitor protects the liver from ischemia/reperfusion-induced injury via elevated glycolytic flux and enhanced sirtuin 1 activity. Zhang C; Li X; Liu Q Mol Med Rep; 2015 Jan; 11(1):283-8. PubMed ID: 25333577 [TBL] [Abstract][Full Text] [Related]
11. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats. Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586 [TBL] [Abstract][Full Text] [Related]
12. Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury. Ananthakrishnan R; Li Q; Gomes T; Schmidt AM; Ramasamy R Exp Gerontol; 2011 Sep; 46(9):762-7. PubMed ID: 21600277 [TBL] [Abstract][Full Text] [Related]
13. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298 [TBL] [Abstract][Full Text] [Related]
14. Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Tang WH; Wu S; Wong TM; Chung SK; Chung SS Free Radic Biol Med; 2008 Sep; 45(5):602-10. PubMed ID: 18549825 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, pharmacodynamics, tolerability, and safety of a novel sorbitol dehydrogenase inhibitor in healthy participants. Landau Z; Novotny MJ; Preston GM; Wright K; Freeman T; Dai H; Thompson J; Oates PJ; Calle RA J Clin Pharmacol; 2010 May; 50(5):521-30. PubMed ID: 20220044 [TBL] [Abstract][Full Text] [Related]
16. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401 [TBL] [Abstract][Full Text] [Related]
17. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart. Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192 [TBL] [Abstract][Full Text] [Related]
19. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release. Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834 [TBL] [Abstract][Full Text] [Related]